Researchers use iPS cells to produce hematopoietic stem cells

05/16/2013 | Mainichi (Japan), The

Researchers in Japan said they were able to create hematopoietic stem cells from induced pluripotent stem cells. The method involved inducing benign tumors in mice using iPS cells and then adding catalysts to trigger the formation of blood-producing stem cells. The team hopes to develop a method for creating cells that does not rely on the use of tumors.

View Full Article in:

Mainichi (Japan), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI